GlassScriptPhysician profile
Suzanne Calcutt
NPI 1467077610
$1,599.57
in general payments reported to CMS, 2019-2025
17 companies · $874 in 2025
The $874 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $725 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $425.32 | 2024-2025 | Injectafer |
| Novo Nordisk INC | $233.67 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Hologic Sales and Service, LLC | $136.12 | 2024-2025 | Aptima |
| Heartflow, INC. | $125.25 | 2025 | |
| Sanofi-Aventis U.S. LLC | $100.64 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.19 | 2024-2025 | Xifaxan |
| Exact Sciences Corporation | $93.00 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $69.92 | 2024-2025 | |
| Pfizer INC. | $61.38 | 2024-2025 | |
| Viiv Healthcare Company | $49.99 | 2025 | Apretude |
| Lilly USA, LLC | $43.55 | 2024-2025 | Mounjaro, Zepbound |
| Emd Serono, INC. | $35.77 | 2024-2025 | |
| Philips North America LLC | $33.94 | 2024 | (Ck7) Extended Holter |
| Phadia US INC. | $31.87 | 2024 | Immunocap |
| Nevro Corp. | $27.65 | 2024 | Senza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.83 | 2025 | Shingrix |
| Dexcom, INC. | $15.48 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Calcutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.